SEC ownership of NEVRO CORP

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001444380.

Comparable stake leader

Shay Capital LLC

Disclosed value leader

Shay Capital LLC

Comparable rows

2/6

Latest evidence

30 Jun 2025

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
2 of 6
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Shay Capital LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2025
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001444380
Issuer location
Redwood City, CA

Ownership snapshot

Top shareholders of NEVRO CORP (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Shay Capital LLC
Disclosed value leader
Shay Capital LLC
Comparable rows
2/6
Latest evidence
30 Jun 2025
13D/G 3/4/5 Lead comparable stake: 4.2% 4 rows are not safely comparable across share classes. 13D/G row: Shay Capital LLC

Quick read

Shay Capital LLC leads the comparable SEC ownership view at 4.2%.

2 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Shay Capital LLC's linked filing trail.
Comparable ownership Top 2
Shay Capital LLC 4.2%
GOLDMAN SACHS GROUP INC 0.02%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 6 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Shay Capital LLC
13D/G
4.2%
$9,179,090
1,571,762 shares
$0 31 Dec 2024
GOLDMAN SACHS GROUP INC
13D/G
THE GOLDMAN SACHS GROUP, INC.
0.02%
$6,844
1,172 shares
-$13,461,001 30 Jun 2025
Niamh Louise Pellegrini
3/4/5
Chief Commercial Officer
class O/S missing
$1,666,900
85,967 shares
28 May 2023
Frank M. Fischer
3/4/5
Director
class O/S missing
$861,925
57,500 shares
31 Mar 2024
Richard B. Carter
3/4/5
Chief Accounting Officer
class O/S missing
$775,897
50,646 shares
07 Mar 2024
Brad Vale
3/4/5
Director
class O/S missing
$158,959
8,198 shares
25 May 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 22 Jun 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-18 of 18 reporting-owner rows connected to NEVRO CORP. Open a relationship link for the CIK-to-CIK filing trail.

Rows
18
Largest Forms 3/4/5 holder
Niamh Louise Pellegrini
Net 12M change
$0
Latest report
03 Apr 2025
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Niamh Louise Pellegrini Chief Commercial Officer $1,666,900 Mixed 28 May 2023
Frank M. Fischer Director $861,925 Mixed 31 Mar 2024
Richard B. Carter Chief Accounting Officer $775,897 Mixed 07 Mar 2024
Brad Vale Director $158,959 Mixed 25 May 2021
Christofer Christoforou SVP, Chief Operating Officer $0 Mixed 03 Apr 2025
Michael F. DeMane Director $0 Mixed 03 Apr 2025
Karen Prange Director $0 Mixed 03 Apr 2025
Shawn mcCormick Director $0 Mixed 03 Apr 2025
Kashif Rashid SVP, Corp Dev and CLO $0 Mixed 03 Apr 2025
Greg Siller SVP & Chief Commercial Officer $0 Mixed 03 Apr 2025
Susan E. Siegel Director $0 Mixed 03 Apr 2025
D. Keith Grossman Director $0 Mixed 03 Apr 2025
Sridhar Kosaraju Director $0 Mixed 03 Apr 2025
Roderick H. MacLeod SVP, Chief Financial Officer $0 Mixed 03 Apr 2025
Elizabeth H. Weatherman Director $0 Mixed 03 Apr 2025
Kevin C. Oboyle Director $0 Mixed 03 Apr 2025
Kirt P. Karros Director $0 Mixed 03 Apr 2025
Kevin R. Thornal President & CEO, Director $0 Mixed 03 Apr 2025

Recent insider transactions for NEVRO CORP

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .